Tenders Are Invited For Development Of Dengue Virus Tetravalent Ns1 And E Vaccine Using The Herpes Simplex Virus Delta-G(Gjdi)-2 Vector

Tender Detail

55231490
1301017463
Self-Funded
Tenders Are Invited For Development Of Dengue Virus Tetravalent Ns1 And E Vaccine Using The Herpes Simplex Virus Delta-G(Gjdi)-2 Vector
ICB
Northern America
Asia-Pacific Economic Cooperation, APEC,APAC ( Asia Pacific)
25-09-2022

Work Detail

Development Of Dengue Virus Tetravalent Ns1 And E Vaccine Using The Herpes Simplex Virus Delta-G(Gjdi)-2 Vector/Rnaics Code: 541715 - Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)/R Product Service Code: An25 - Health R&Amp;D Services; Health Research And Training; Expenses For R&Amp;D Facilities And Major Equipment

Key Value

Tender Value
Refer document

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail